Adjunctive nano‐curcumin therapy improves inflammatory and clinical indices in children with cystic fibrosis: A randomized clinical trial
Open Access
- 28 March 2023
- journal article
- research article
- Published by Wiley in Food Science & Nutrition
- Vol. 11 (6) , 3348-3357
Abstract
Inflammation may develop due to internal dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR) protein or external factors in patients with cystic fibrosis (CF). This prospective randomized clinical trial aimed to ascertain the effects of nano‐curcumin as an anti‐inflammatory agent and a CFTR modulator on clinical and inflammatory markers in children with CF. Children with CF were randomly assigned to receive daily curcumin or a placebo for 3 months. The primary outcome measure was to evaluate inflammatory indices, nasopharyngeal swab analysis, and clinical assessments via spirometry, anthropometric measurements, and quality of life (QOL) analysis. Sixty children were included. Intra‐group changes comparison showed that curcumin decreased the level of high‐sensitivity C‐reactive protein (hs‐CRP) (median: −0.31 mg/L, IQR: −1.53 to 0.81; p = .01) and fecal calprotectin level (−29 μg/g, −57.5 to 11.5; p = .03), also increased the level of interleukin (IL)‐10 (6.1 pg/mL, 4.5–9; p = .01). Moreover, curcumin improved the overall QOL and the subscales of the questionnaire. Inter‐group changes comparison depicted the number of Pseudomonas colonies reduced by about 52% in the curcumin group and gained weight by about 16% (p > .05). Nano‐curcumin seems to be considered as an effective nutritional supplement on hs‐CRP, IL‐10, fecal calprotectin levels, and improving QOL in patients with CF.Keywords
Funding Information
- Mashhad University of Medical Sciences
This publication has 48 references indexed in Scilit:
- Therapeutic Roles of Curcumin: Lessons Learned from Clinical TrialsThe AAPS Journal, 2012
- Discovery of curcumin, a component of golden spice, and its miraculous biological activitiesClinical and Experimental Pharmacology and Physiology, 2011
- Curcumin and genistein additively potentiate G551D-CFTRJournal of Cystic Fibrosis, 2011
- Curcumin's Effect on Intestinal Inflammation and Tumorigenesis in the Apc
Min/+
MouseJournal of Interferon & Cytokine Research, 2011
- Acute-phase proteins: As diagnostic toolJournal of Pharmacy and Bioallied Sciences, 2011
- Anti-Inflammatory Effects of Resveratrol, Curcumin and Simvastatin in Acute Small Intestinal InflammationPLOS ONE, 2010
- Potential of anti-inflammatory treatment for cystic fibrosis lung diseaseJournal of Inflammation Research, 2010
- Partial Correction of Cystic Fibrosis Defects with PLGA Nanoparticles Encapsulating CurcuminMolecular Pharmaceutics, 2009
- Rescue of ΔF508-CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) by Curcumin: Involvement of the Keratin 18 NetworkThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Cystic fibrosis: recent structural insightsJournal of Cystic Fibrosis, 2004